This website uses third-party profiling cookies to provide services in line with the preferences you reveal while browsing the Website. By continuing to browse this Website, you consent to the use of these cookies. If you want to object such processing, please read the instructions described in our Cookie Policy.

Justin Gover

GW Pharma

In two decades at cannabis-based pharma company GW Pharma in Cambridge, 48-year-old Gover has transformed a greenhouse full of weed into a $4.5bn drugs company that has two approved medicines for multiple sclerosis and epilepsy. It was the first drug maker to win approval for a pharmaceutical-standard medicine derived from the cannabis plant, in an industry that is rapidly growing. 

Request a Test Drive, a Quote or More Information